Review



recombinant human wnt 3a protein  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress recombinant human wnt 3a protein
    Recombinant Human Wnt 3a Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wnt3a+surrogate+protein/Wnt3a+Surrogate%2C+Human/pmc12807938-3-0-8
    Average 94 stars, based on 2 article reviews
    recombinant human wnt 3a protein - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Transfection:

    Article Title: Evolutionary Dampening of Wnt Signaling May Contribute to Naturally Ascrotal Testes in Mammals
    Article Snippet: .. After 24 to 48 h of transfection, the cells were treated with Wnt3a Surrogate Protein (MedChemExpress) or control treatments. ..

    Control:

    Article Title: Evolutionary Dampening of Wnt Signaling May Contribute to Naturally Ascrotal Testes in Mammals
    Article Snippet: .. After 24 to 48 h of transfection, the cells were treated with Wnt3a Surrogate Protein (MedChemExpress) or control treatments. ..



    Similar Products

    94
    MedChemExpress recombinant human wnt 3a protein
    Recombinant Human Wnt 3a Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wnt3a+surrogate+protein/Wnt3a+Surrogate%2C+Human/pmc12807938-3-0-8
    Average 94 stars, based on 1 article reviews
    recombinant human wnt 3a protein - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    MedChemExpress wnt3a surrogate protein
    Functional modifications in ZNRF3 induced by species with different testicular positions and amino acid changes at residue 406. a) to c) Presents the total biding energy (ΔG) of molecular docking between ZNRF3- and DVL1, DVL2, and DVL3, with lower ΔG values indicating stronger binding affinity. d) S406G mutation enhances the inhibitory effect of ZNRF3 on Wnt signaling pathway. Relative luciferase activity was measured using the TOPFlash reporter assay. The EV group represents cells transfected with an empty vector without <t>Wnt3a</t> treatment, while the Control group refers to empty vector-transfected cells treated with Wnt3a (60 ng/mL). All other groups were treated with Wnt3a. Data are displayed as mean ± SD ( n > 3). (**** P < 0.0001; *** P < 0.001; ns, not significant). e) Representative images of scratch assays performed on Hela cells expressing ZNRF3 wild-type and mutant variants from human (S406G), dolphin (G406S), and elephant (G406S) at 0 and 48 h. All groups, except the empty vector (EV) group, were treated with 100 ng/mL Wnt3a. Dashed lines indicate the wound edges, and cell migration was quantified by measuring wound closure at 48 h. Scale bar = 100 μm. f) Quantification of cell migration percentage (mean ± SD) across groups (one-way ANOVA, n = 3; * P < 0.05, ** P < 0.01, **** P < 0.0001, ns: not significant).
    Wnt3a Surrogate Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wnt3a+surrogate+protein/Wnt3a+Surrogate%2C+Human/pmc12684726-100-12-15
    Average 93 stars, based on 1 article reviews
    wnt3a surrogate protein - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress wnt3a 6 surrogate protein
    Functional modifications in ZNRF3 induced by species with different testicular positions and amino acid changes at residue 406. a) to c) Presents the total biding energy (ΔG) of molecular docking between ZNRF3- and DVL1, DVL2, and DVL3, with lower ΔG values indicating stronger binding affinity. d) S406G mutation enhances the inhibitory effect of ZNRF3 on Wnt signaling pathway. Relative luciferase activity was measured using the TOPFlash reporter assay. The EV group represents cells transfected with an empty vector without <t>Wnt3a</t> treatment, while the Control group refers to empty vector-transfected cells treated with Wnt3a (60 ng/mL). All other groups were treated with Wnt3a. Data are displayed as mean ± SD ( n > 3). (**** P < 0.0001; *** P < 0.001; ns, not significant). e) Representative images of scratch assays performed on Hela cells expressing ZNRF3 wild-type and mutant variants from human (S406G), dolphin (G406S), and elephant (G406S) at 0 and 48 h. All groups, except the empty vector (EV) group, were treated with 100 ng/mL Wnt3a. Dashed lines indicate the wound edges, and cell migration was quantified by measuring wound closure at 48 h. Scale bar = 100 μm. f) Quantification of cell migration percentage (mean ± SD) across groups (one-way ANOVA, n = 3; * P < 0.05, ** P < 0.01, **** P < 0.0001, ns: not significant).
    Wnt3a 6 Surrogate Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wnt3a+surrogate+protein/Wnt3a+Surrogate%2C+Human/pm41293833-119-12-16
    Average 93 stars, based on 1 article reviews
    wnt3a 6 surrogate protein - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    MedChemExpress wnt3a fc surrogate protein
    Functional modifications in ZNRF3 induced by species with different testicular positions and amino acid changes at residue 406. a) to c) Presents the total biding energy (ΔG) of molecular docking between ZNRF3- and DVL1, DVL2, and DVL3, with lower ΔG values indicating stronger binding affinity. d) S406G mutation enhances the inhibitory effect of ZNRF3 on Wnt signaling pathway. Relative luciferase activity was measured using the TOPFlash reporter assay. The EV group represents cells transfected with an empty vector without <t>Wnt3a</t> treatment, while the Control group refers to empty vector-transfected cells treated with Wnt3a (60 ng/mL). All other groups were treated with Wnt3a. Data are displayed as mean ± SD ( n > 3). (**** P < 0.0001; *** P < 0.001; ns, not significant). e) Representative images of scratch assays performed on Hela cells expressing ZNRF3 wild-type and mutant variants from human (S406G), dolphin (G406S), and elephant (G406S) at 0 and 48 h. All groups, except the empty vector (EV) group, were treated with 100 ng/mL Wnt3a. Dashed lines indicate the wound edges, and cell migration was quantified by measuring wound closure at 48 h. Scale bar = 100 μm. f) Quantification of cell migration percentage (mean ± SD) across groups (one-way ANOVA, n = 3; * P < 0.05, ** P < 0.01, **** P < 0.0001, ns: not significant).
    Wnt3a Fc Surrogate Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wnt3a+surrogate+protein/Wnt3a+Surrogate%2C+Human/pm40818454-447-27-30
    Average 94 stars, based on 1 article reviews
    wnt3a fc surrogate protein - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    ImmunoPrecise wnt3a surrogate-fc fusion protein
    List of materials and equipment including vendors.
    Wnt3a Surrogate Fc Fusion Protein, supplied by ImmunoPrecise, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wnt3a+surrogate+protein/wnt3a/pmc10548204-66-0-8
    Average 90 stars, based on 1 article reviews
    wnt3a surrogate-fc fusion protein - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Functional modifications in ZNRF3 induced by species with different testicular positions and amino acid changes at residue 406. a) to c) Presents the total biding energy (ΔG) of molecular docking between ZNRF3- and DVL1, DVL2, and DVL3, with lower ΔG values indicating stronger binding affinity. d) S406G mutation enhances the inhibitory effect of ZNRF3 on Wnt signaling pathway. Relative luciferase activity was measured using the TOPFlash reporter assay. The EV group represents cells transfected with an empty vector without Wnt3a treatment, while the Control group refers to empty vector-transfected cells treated with Wnt3a (60 ng/mL). All other groups were treated with Wnt3a. Data are displayed as mean ± SD ( n > 3). (**** P < 0.0001; *** P < 0.001; ns, not significant). e) Representative images of scratch assays performed on Hela cells expressing ZNRF3 wild-type and mutant variants from human (S406G), dolphin (G406S), and elephant (G406S) at 0 and 48 h. All groups, except the empty vector (EV) group, were treated with 100 ng/mL Wnt3a. Dashed lines indicate the wound edges, and cell migration was quantified by measuring wound closure at 48 h. Scale bar = 100 μm. f) Quantification of cell migration percentage (mean ± SD) across groups (one-way ANOVA, n = 3; * P < 0.05, ** P < 0.01, **** P < 0.0001, ns: not significant).

    Journal: Molecular Biology and Evolution

    Article Title: Evolutionary Dampening of Wnt Signaling May Contribute to Naturally Ascrotal Testes in Mammals

    doi: 10.1093/molbev/msaf310

    Figure Lengend Snippet: Functional modifications in ZNRF3 induced by species with different testicular positions and amino acid changes at residue 406. a) to c) Presents the total biding energy (ΔG) of molecular docking between ZNRF3- and DVL1, DVL2, and DVL3, with lower ΔG values indicating stronger binding affinity. d) S406G mutation enhances the inhibitory effect of ZNRF3 on Wnt signaling pathway. Relative luciferase activity was measured using the TOPFlash reporter assay. The EV group represents cells transfected with an empty vector without Wnt3a treatment, while the Control group refers to empty vector-transfected cells treated with Wnt3a (60 ng/mL). All other groups were treated with Wnt3a. Data are displayed as mean ± SD ( n > 3). (**** P < 0.0001; *** P < 0.001; ns, not significant). e) Representative images of scratch assays performed on Hela cells expressing ZNRF3 wild-type and mutant variants from human (S406G), dolphin (G406S), and elephant (G406S) at 0 and 48 h. All groups, except the empty vector (EV) group, were treated with 100 ng/mL Wnt3a. Dashed lines indicate the wound edges, and cell migration was quantified by measuring wound closure at 48 h. Scale bar = 100 μm. f) Quantification of cell migration percentage (mean ± SD) across groups (one-way ANOVA, n = 3; * P < 0.05, ** P < 0.01, **** P < 0.0001, ns: not significant).

    Article Snippet: After 24 to 48 h of transfection, the cells were treated with Wnt3a Surrogate Protein (MedChemExpress) or control treatments.

    Techniques: Functional Assay, Residue, Binding Assay, Mutagenesis, Luciferase, Activity Assay, Reporter Assay, Transfection, Plasmid Preparation, Control, Expressing, Migration

    List of materials and equipment including vendors.

    Journal: Frontiers in Immunology

    Article Title: A liquid chromatography-tandem mass spectrometry based method for the quantification of adenosine nucleotides and NAD precursors and products in various biological samples

    doi: 10.3389/fimmu.2023.1250762

    Figure Lengend Snippet: List of materials and equipment including vendors.

    Article Snippet: Wnt3a Surrogate-Fc Fusion Protein , 0.3 nM , ImmunoPrecise Antibodies.

    Techniques: Control, Clinical Proteomics, Cell Culture, Membrane, Targeted Proteomics, Mass Spectrometry, Software